Does HLA-DQ8 increase celiac disease risk and do IL23R variants alter IBD susceptibility?

Clinical and genetic risk associations

Large-scale genetic and clinical evidence supports both elements of the claim, establishing clear associations between specific genetic variations and gastrointestinal disease susceptibility:

• Celiac Disease Risk: HLA-DQ8 is a critical genetic risk factor for celiac disease. Clinical testing for tag SNPs (such as rs7454108) reveals that HLA-DQ8 (along with HLA-DQ2) is present in the vast majority of celiac patients. Its primary clinical utility lies in its exceptional negative predictive value, as individuals lacking these haplotypes are highly unlikely to develop the condition.
• Inflammatory Bowel Disease (IBD) Susceptibility: Genetic variations in the IL-23 receptor gene (IL23R), particularly the rs11209026 (Arg381Gln or R381Q) single nucleotide polymorphism, strongly modulate susceptibility to Crohn’s disease and ulcerative colitis.

Molecular and mucosal immune mechanisms

Pathological processes in both diseases rely on specific receptor-ligand interactions that drive chronic mucosal inflammation:

• Gluten Antigen Presentation: The HLA-DQ8 heterodimer features a distinct peptide-binding groove that preferentially binds deamidated gluten (gliadin) peptides, which have been modified by tissue transglutaminase 2 (TG2). This efficient binding facilitates antigen presentation to intestinal CD4+ T cells, initiating the enteropathy.
• IL-23/Th17 Signaling Cascade: The protective IL23R A-allele (Gln381) acts as a hypomorphic variant that destabilizes the IL-23 receptor and reduces its surface expression. This impairs downstream Janus kinase 2 (JAK2) and tyrosine kinase 2 (TYK2) activation, which diminishes STAT3 phosphorylation. Consequently, downstream transcription of pro-inflammatory Th17 cytokines (IL-17A, IL-17F, and IL-22) is suppressed, protecting against the chronic mucosal tissue damage characteristic of IBD. Conversely, the wild-type G-allele (Arg381) permits unattenuated signaling, sustaining mucosal inflammation.

Bottom line

• Both HLA-DQ8 and IL23R genetic variations are strongly linked to intestinal inflammatory diseases, acting through distinct molecular mechanisms: HLA-DQ8 coordinates deamidated gluten peptide presentation to T cells in celiac disease, while IL23R polymorphisms dictate the magnitude of the pro-inflammatory IL-23/Th17 mucosal immune response in IBD.